In patients with VaD, plasma prothrombin levels were increased and systemic thrombin inhibition has been shown to improve cerebral metabolism in patients with silent cerebrovascular disease (Kario et al., 1996, 1999). The gene discussed is F2; the disease is cerebrovascular disorder.